Premium
Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus
Author(s) -
Kirtschig G.,
Becker K.,
Günthert A.,
Jasaitiene D.,
Cooper S.,
Chi C.C.,
Kreuter A.,
Rall K.K.,
Aberer W.,
Riechardt S.,
Casabona F.,
Powell J.,
Brackenbury F.,
Erdmann R.,
Lazzeri M.,
Barbagli G.,
Wojnarowska F.
Publication year - 2015
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.13136
Subject(s) - lichen sclerosus , medicine , guideline , dermatology , disease , gynecology , pathology
Lichen sclerosus (LS) is an inflammatory skin disease that usually involves the anogenital area. All patients with symptoms or signs suspicious of lichen sclerosus should be seen at least once initially by a physician with a special interest in the disease in order to avoid delay in diagnosis, as early treatment may cure the disease in some and reduce or prevent scarring. The diagnosis is made clinically in most cases. Biopsies should only be performed under certain circumstances. The gold standard for treatment remains potent to very potent topical steroids; however, mild and moderate disease in boys and men may be cured by circumcision. Certain triggers should be avoided. http://www.euroderm.org/images/stories/guidelines/2014/S3-Guideline-on-Lichen-sclerosus.pdf http://www.awmf.org/fachgesellschaften/mitgliedsgesellschaften/visitenkarte/fg/deutsche-gesellschaft-fuer-gynaekologie-und-geburtshilfe-dggg.html.